Inspire Medical Systems at the 2025 Healthcare Conference
Inspire Medical Systems, Inc. (NYSE: INSP), recognized for its pioneering role in the medical technology sector, is gearing up to showcase its advancements at an upcoming healthcare conference. The focus of the event is largely centered around innovative solutions for patients suffering from obstructive sleep apnea.
Event Details and Presentation Insights
The management of Inspire Medical Systems will be presenting at the Wells Fargo 2025 Healthcare Conference. Scheduled for a morning slot on September 3, 2025, at 11:00 a.m. Eastern Time, attendees can expect insights into the company's groundbreaking work and the role of Inspire therapy in treating obstructive sleep apnea.
Live Webcast Information
For those unable to attend in person, there will be an opportunity to view the presentation through a live webcast. This accessibility enhances the reach of Inspire’s messaging, ensuring stakeholders can stay engaged with the company’s developments. The webcast will be available for a two-week period following the presentation, allowing for additional access to the insights shared.
Innovative Therapies That Transform Lives
Inspire Medical Systems specializes in creating innovative, minimally invasive therapies aimed at improving the quality of life for patients. Their proprietary Inspire therapy is recognized as the first neurostimulation technology approved by regulatory bodies such as the FDA, EU MDR, and PMDA. This technology offers a safe and effective solution for individuals suffering from moderate to severe obstructive sleep apnea, a condition that significantly impacts health and well-being.
More on Inspire Medical Systems
As a leader in medical technology, Inspire is dedicated to the continuous development and commercialization of solutions that address unmet medical needs. Their commitment to innovation and patient care positions them at the forefront of transforming the sleep apnea treatment landscape. Individuals and professionals interested in learning more about Inspire’s offerings and their mission can find detailed information on their official website.
Contact Information for Investor Relations
For inquiries, investors and media representatives are encouraged to contact Ezgi Yagci, Vice President of Investor Relations. Direct communication lines are open via email at ezgiyagci@inspiresleep.com or by phone at 617-549-2443. This connection reinforces Inspire’s commitment to transparency and engagement with its stakeholders.
Frequently Asked Questions
What is Inspire Medical Systems known for?
Inspire Medical Systems is recognized for developing innovative solutions for obstructive sleep apnea through its Inspire therapy.
When is Inspire Medical Systems presenting at the conference?
The presentation is scheduled for September 3, 2025, at 11:00 a.m. Eastern Time.
How can I access the presentation?
The presentation will be accessible through a live webcast, with a replay available for two weeks afterward.
What is Inspire therapy?
Inspire therapy is a neurostimulation technology designed to treat moderate to severe obstructive sleep apnea, approved by the FDA and other regulatory bodies.
How can I contact Inspire Medical Systems for more information?
For further inquiries, you can reach out to Ezgi Yagci via email at ezgiyagci@inspiresleep.com or call 617-549-2443.
